DE69630710D1 - Humaner tumornekrosefaktor delta und epsilon - Google Patents
Humaner tumornekrosefaktor delta und epsilonInfo
- Publication number
- DE69630710D1 DE69630710D1 DE69630710T DE69630710T DE69630710D1 DE 69630710 D1 DE69630710 D1 DE 69630710D1 DE 69630710 T DE69630710 T DE 69630710T DE 69630710 T DE69630710 T DE 69630710T DE 69630710 D1 DE69630710 D1 DE 69630710D1
- Authority
- DE
- Germany
- Prior art keywords
- epsilon
- polypeptides
- human
- tumorne
- factor delta
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/52—Cytokines; Lymphokines; Interferons
- C07K14/525—Tumour necrosis factor [TNF]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Veterinary Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Physical Education & Sports Medicine (AREA)
- Immunology (AREA)
- Rheumatology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Genetics & Genomics (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Pain & Pain Management (AREA)
- Endocrinology (AREA)
- Toxicology (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Obesity (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Emergency Medicine (AREA)
- Transplantation (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PCT/US1996/003774 WO1997033902A1 (en) | 1996-03-14 | 1996-03-14 | Human tumor necrosis factor delta and epsilon |
CA2247285A CA2247285C (en) | 1996-03-14 | 1996-03-14 | Human tumor necrosis factor delta and epsilon |
CN96180213A CN1214050A (zh) | 1996-03-14 | 1996-03-14 | 人肿瘤坏死因子δ和ε |
Publications (2)
Publication Number | Publication Date |
---|---|
DE69630710D1 true DE69630710D1 (de) | 2003-12-18 |
DE69630710T2 DE69630710T2 (de) | 2004-09-23 |
Family
ID=27170805
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE69630710T Expired - Lifetime DE69630710T2 (de) | 1996-03-14 | 1996-03-14 | Humaner tumornekrosefaktor delta und epsilon |
Country Status (11)
Country | Link |
---|---|
EP (2) | EP1362916A3 (de) |
JP (1) | JP2001501453A (de) |
CN (1) | CN1214050A (de) |
AT (1) | ATE254135T1 (de) |
AU (1) | AU726486C (de) |
CA (1) | CA2247285C (de) |
DE (1) | DE69630710T2 (de) |
DK (1) | DK0897390T3 (de) |
ES (1) | ES2210354T3 (de) |
PT (1) | PT897390E (de) |
WO (1) | WO1997033902A1 (de) |
Families Citing this family (44)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7888466B2 (en) | 1996-01-11 | 2011-02-15 | Human Genome Sciences, Inc. | Human G-protein chemokine receptor HSATU68 |
US7217788B2 (en) | 1996-03-14 | 2007-05-15 | Human Genome Sciences, Inc. | Human tumor necrosis factor delta polypeptides |
US6541224B2 (en) | 1996-03-14 | 2003-04-01 | Human Genome Sciences, Inc. | Tumor necrosis factor delta polypeptides |
ATE275630T1 (de) | 1996-07-19 | 2004-09-15 | Takeda Chemical Industries Ltd | Fas ligand ähnliches protein, seine herstellung und verwendung |
US6812327B1 (en) | 1996-10-25 | 2004-11-02 | Human Genome Sciences, Inc. | Neutrokine-alpha polypeptides |
US6689579B1 (en) | 1996-10-25 | 2004-02-10 | Human Genome Sciences, Inc. | Polynucleotides encoding neutrokine-α |
US6171787B1 (en) * | 1997-06-26 | 2001-01-09 | Abbott Laboratories | Member of the TNF family useful for treatment and diagnosis of disease |
WO1999011791A2 (en) * | 1997-09-05 | 1999-03-11 | University Of Washington | Tumor necrosis factor family receptors and ligands, encoding nucleic acids and related binding agents |
WO1999012965A2 (en) * | 1997-09-12 | 1999-03-18 | Biogen, Inc. | April- a novel protein with growth effects |
US6440694B1 (en) * | 1997-09-30 | 2002-08-27 | Pharmacia & Upjohn Company | TNF-related death ligand |
US6297022B1 (en) * | 1997-10-08 | 2001-10-02 | Smithkline Beecham Corporation | Method of identifying agonists and antagonists for tumor necrosis related receptor TR1 |
JP2002503444A (ja) * | 1997-11-26 | 2002-02-05 | イーライ・リリー・アンド・カンパニー | リガンドファミリー遺伝子 |
AU1700999A (en) * | 1997-11-26 | 1999-06-15 | Eli Lilly And Company | Tnf ligand family gene |
US6297367B1 (en) | 1997-12-30 | 2001-10-02 | Chiron Corporation | Polynucleotide encoding TNFL1 |
AU2093499A (en) * | 1997-12-30 | 1999-07-19 | Chiron Corporation | Members of tnf and tnfr families |
US6365369B1 (en) * | 1998-04-01 | 2002-04-02 | Human Genome Sciences, Inc. | Prostate specific secreted protein |
ES2151403B1 (es) * | 1998-07-13 | 2001-07-01 | Hernandez Bronchud Miguel | Linea celular transformada de rata productora de tnf-alfa humano recombinante. |
AU1467000A (en) * | 1998-11-04 | 2000-05-22 | Government Of The United States Of America, As Represented By The Secretary Of The Department Of Health And Human Services, The | A novel tumor necrosis factor family member, drl, and related compositions and methods |
US7833529B1 (en) | 1999-01-07 | 2010-11-16 | Zymogenetics, Inc. | Methods for inhibiting B lymphocyte proliferation with soluble ztnf4 receptor |
CN100340292C (zh) | 1999-01-25 | 2007-10-03 | 比奥根艾迪克Ma公司 | Baff,其封闭剂以及它们在b细胞应答的调节中的应用 |
US20030095967A1 (en) | 1999-01-25 | 2003-05-22 | Mackay Fabienne | BAFF, inhibitors thereof and their use in the modulation of B-cell response and treatment of autoimmune disorders |
US20030022233A1 (en) | 1999-04-30 | 2003-01-30 | Raymond G. Goodwin | Methods of use of the taci/taci-l interaction |
EP2314694A3 (de) | 1999-08-17 | 2013-12-11 | Biogen Idec MA Inc. | BAFF rezeptor (BCMA), ein immunoregulatorisches Mittel |
UA74798C2 (uk) | 1999-10-06 | 2006-02-15 | Байоджен Айдек Ма Інк. | Спосіб лікування раку у ссавця за допомогою поліпептиду, що протидіє взаємодії april з його рецепторами |
WO2001058949A2 (en) | 2000-02-11 | 2001-08-16 | Biogen, Inc. | Heterologous polypeptide of the tnf family |
DE60028830T2 (de) | 2000-02-16 | 2007-01-18 | Genentech, Inc., South San Francisco | Anti-april antikörper und hybridomazellen |
EP1294949A4 (de) * | 2000-06-15 | 2004-08-25 | Human Genome Sciences Inc | Menschlicher tumornekrosefaktor delta und epsilon |
US7220840B2 (en) | 2000-06-16 | 2007-05-22 | Human Genome Sciences, Inc. | Antibodies that immunospecifically bind to B lymphocyte stimulator protein |
AU6842701A (en) | 2000-06-16 | 2002-01-14 | Human Genome Sciences Inc | Antibodies that immunospecifically bind to blys |
US20030091565A1 (en) | 2000-08-18 | 2003-05-15 | Beltzer James P. | Binding polypeptides and methods based thereon |
UA83458C2 (uk) | 2000-09-18 | 2008-07-25 | Байоджен Айдек Ма Інк. | Виділений поліпептид baff-r (рецептор фактора активації в-клітин сімейства tnf) |
EP1401870A4 (de) | 2001-05-24 | 2006-04-19 | Human Genome Sciences | Antikörper gegen tumor necrosis factor delta (april) |
DK2116259T3 (da) | 2001-05-24 | 2012-05-21 | Zymogenetics Inc | TACI-immunoglobulinfusionsproteiner |
WO2004094620A2 (en) | 2003-03-28 | 2004-11-04 | Biogen Idec Ma Inc. | Truncated baff receptors |
CA2554526A1 (en) * | 2004-01-29 | 2005-08-18 | Genentech, Inc. | Variants of the extracellular domain of bcma and uses thereof |
US20050186577A1 (en) | 2004-02-20 | 2005-08-25 | Yixin Wang | Breast cancer prognostics |
JP5118037B2 (ja) | 2005-08-09 | 2013-01-16 | ザイモジェネティクス, インコーポレイテッド | Taci融合分子を用いた異常細胞増殖の処置及び予防のための方法 |
AR059945A1 (es) | 2005-08-09 | 2008-05-14 | Zymogenetics Inc | Metodos para tratar afecciones malignas de celulas b que utilizan una molecula de fusion taci-ig |
US9168286B2 (en) | 2005-10-13 | 2015-10-27 | Human Genome Sciences, Inc. | Methods and compositions for use in treatment of patients with autoantibody positive disease |
AU2006344395B2 (en) | 2005-10-13 | 2013-05-02 | Human Genome Sciences, Inc. | Methods and compositions for use in treatment of patients with autoantibody positive diseases |
AU2006318539B2 (en) | 2005-11-23 | 2012-09-13 | Genentech, Inc. | Methods and compositions related to B cell assays |
WO2007123765A2 (en) | 2006-03-31 | 2007-11-01 | Human Genome Sciences Inc. | Neutrokine-alpha and neutrokine-alpha splice variant |
UA98462C2 (ru) | 2006-05-15 | 2012-05-25 | Арес Трейдинг С.А. | Способы лечения аутоиммунных заболеваний с использованием слитой молекулы taci-ig |
WO2011109280A1 (en) | 2010-03-05 | 2011-09-09 | Lerner Research Institute | Methods and compositions to treat immune-mediated disorders |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0368367A1 (de) * | 1984-12-21 | 1990-05-16 | Biogen, Inc. | Reinigung, Herstellung und Verwendung von Tumornekrosefaktoren |
-
1996
- 1996-03-14 PT PT96910483T patent/PT897390E/pt unknown
- 1996-03-14 AU AU53665/96A patent/AU726486C/en not_active Ceased
- 1996-03-14 WO PCT/US1996/003774 patent/WO1997033902A1/en active IP Right Grant
- 1996-03-14 CA CA2247285A patent/CA2247285C/en not_active Expired - Lifetime
- 1996-03-14 ES ES96910483T patent/ES2210354T3/es not_active Expired - Lifetime
- 1996-03-14 DE DE69630710T patent/DE69630710T2/de not_active Expired - Lifetime
- 1996-03-14 JP JP09532553A patent/JP2001501453A/ja active Pending
- 1996-03-14 EP EP03012254A patent/EP1362916A3/de not_active Withdrawn
- 1996-03-14 EP EP96910483A patent/EP0897390B1/de not_active Expired - Lifetime
- 1996-03-14 CN CN96180213A patent/CN1214050A/zh active Pending
- 1996-03-14 AT AT96910483T patent/ATE254135T1/de active
- 1996-03-14 DK DK96910483T patent/DK0897390T3/da active
Also Published As
Publication number | Publication date |
---|---|
ATE254135T1 (de) | 2003-11-15 |
CA2247285A1 (en) | 1997-09-18 |
EP0897390A1 (de) | 1999-02-24 |
PT897390E (pt) | 2004-03-31 |
CN1214050A (zh) | 1999-04-14 |
EP0897390B1 (de) | 2003-11-12 |
AU726486C (en) | 2004-02-05 |
EP0897390A4 (de) | 1999-04-07 |
AU5366596A (en) | 1997-10-01 |
WO1997033902A1 (en) | 1997-09-18 |
EP1362916A2 (de) | 2003-11-19 |
DK0897390T3 (da) | 2004-03-08 |
CA2247285C (en) | 2011-11-08 |
JP2001501453A (ja) | 2001-02-06 |
DE69630710T2 (de) | 2004-09-23 |
EP1362916A3 (de) | 2004-02-18 |
ES2210354T3 (es) | 2004-07-01 |
AU726486B2 (en) | 2000-11-09 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE69630710D1 (de) | Humaner tumornekrosefaktor delta und epsilon | |
EP0825260A3 (de) | Arginase II | |
ATE407949T1 (de) | Charakterisierung der proteinfamilie von soc/crac kalziumkanälen | |
DE68929551D1 (de) | Menschliche DNase | |
ATE98260T1 (de) | Vorlaeuferprotein des apc-polypeptids, dafuer codierende dna und diagnostische verwendung der dna und des proteins. | |
WO2002014368A3 (en) | Proteins and nucleic acids encoding the same | |
DE69836131D1 (de) | Neue menschliche delta3-zusammensetzung und deren therapeutische und diagnostische verwendungen | |
EP0907719A4 (de) | Menschliches zytokinpolypeptid | |
CY1110961T1 (el) | Πρωτεϊνη παρομοια προς νευροενδοκρινικη-ειδικη πρωτεϊνη και κωδικοποιουσα cdna | |
IL115792A0 (en) | Al-1 neurothophic factor | |
ATE311457T1 (de) | Basb029 polynucleotide und polypeptide aus neisseria meningitis | |
WO2002057450A3 (en) | Proteins and nucleic acids encoding same | |
WO2001096528A3 (en) | Human tumor necrosis factor delta and epsilon | |
WO2001090155A3 (en) | Novx proteins and nucleic acids encoding same. diagnostic and therapeutic uses | |
WO2002016599A3 (en) | Proteins and nucleic acids encoding same | |
EE05293B1 (et) | RG1 polpeptiidiga seonduv antikeha, seda h?lmav immunkonjugaat ja nende kasutamine | |
WO2002029038A3 (en) | Novel proteins and nucleic acids encoding same and antibodies directed against these proteins | |
WO2002018576A3 (en) | Compositions and methods relating to lung specific genes | |
WO2002010216A3 (en) | Proteins and nucleic acids encoding same | |
DK1261712T3 (da) | Proteiner benævnt FXTRC og nucleinsyrer kodende for samme | |
EP0812916A3 (de) | Cathepsin K Gen | |
WO2001061055A3 (en) | Methods for diagnosing, monitoring, staging, imaging and treating lung cancer via lung cancer specific genes | |
WO2002030977A3 (en) | Egf motif protein, egfl6 materials and methods | |
WO2002030974A3 (en) | Proteins and nucleic acids encoding same | |
WO2001094416A3 (en) | Human proteins and nucleic acids encoding same |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8364 | No opposition during term of opposition |